Wyszuk. zaawans.

Tom 9, Nr 1 (2017)
Artykuły
Opublikowany online: 2017-10-26

dostęp otwarty

Pokaż PDF Pobierz plik PDF
Wyświetlenia strony 2197
Wyświetlenia/pobrania artykułu 21374
Pobierz cytowanie

Eksport do Mediów Społecznościowych

Eksport do Mediów Społecznościowych

Zespół pieczenia jamy ustnej

Piotr T. Wysocki
Gastroenterologia Kliniczna 2017;9(1):7-18.

Streszczenie

Zespół pieczenia jamy ustnej (BMS) jest idiopatyczną jednostką chorobową manifestującą się jako długotrwałe uczucie piekącego, palącego lub kłującego bólu w obrębie błon śluzowych jamy ustnej, najczęściej języka. Dolegliwościom bólowym często towarzyszą zaburzenia smaku, uczucie suchości jamy ustnej oraz nieprawidłowości psychiatryczne. Mimo że jest to stosunkowo częste schorzenie, szczególnie w przypadku kobiet w wieku pomenopauzalnym, a jego obraz kliniczny opisuje się w literaturze medycznej od niemal 150 lat, BMS nadal stanowi mało znany problem diagnostyczny i terapeutyczny. Trudności napotykane w praktyce klinicznej są w dużej mierze wynikiem słabo poznanej, wieloczynnikowej etiologii schorzenia, nieobecnością żadnych nieprawidłowości w zakresie morfologii błon śluzowych jamy ustnej oraz niedostatkiem randomizowanych badań weryfikujących skuteczność postępowania leczniczego. Celem tego artykułu jest przybliżenie czytelnikom typowego obrazu klinicznego BMS, ukazanie znaczenia diagnostyki różnicowej zespołu oraz przedstawienie aktualnych danych dotyczących dostępnych sposobów terapii. Znajomość powyższych kwestii przez lekarzy różnych specjalności jest kluczowa dla poprawy jakości życia pacjentów cierpiących na BMS.

Słowa kluczowe: zespół pieczenia jamy ustnejból językadiagnozaleczenie

Artykuł dostępny w formacie PDF

Pokaż PDF Pobierz plik PDF

Referencje

  1. Gilpin S. Glossodynia. Journal of the American Medical Association. 1936; 106(20): 1722–1724.
    CrossRef
  2. Gurvits GE, Tan A. Burning mouth syndrome. World J Gastroenterol. 2013; 19(5): 665–672.
    CrossRefPubMed
  3. IASP. Burning Mouth Syndrome. Fact Sheet 2016. http://iasp.files.cms-plus.com/Content/ContentFolders/GlobalYearAgainstPain2/20132014OrofacialPain/FactSheets/Burning_Mouth_Syndrome_2016.pdf.
  4. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. 2013; 33(9): 629–808.
    CrossRefPubMed
  5. Balasubramaniam R, Klasser GD, Delcanho R. Separating oral burning from burning mouth syndrome: unravelling a diagnostic enigma. Aust Dent J. 2009; 54(4): 293–299.
    CrossRefPubMed
  6. Ferensztajn E, Łojko D, Rybakowski J. [Burning mouth syndrome: pathogenic and therapeutic concepts]. Psychiatr Pol. 2013; 47(6): 973–988.
    PubMed
  7. Mignogna MD, Fedele S, Lo Russo L, et al. The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain. 2005; 19(2): 168–173.
    PubMed
  8. Cheung D, Trudgill N. Managing a patient with burning mouth syndrome. Frontline Gastroenterol. 2015; 6(3): 218–222.
    CrossRefPubMed
  9. McMillan R, Forssell H, Buchanan JAg, et al. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev. 2016; 11: CD002779.
    CrossRefPubMed
  10. Bergdahl M, Bergdahl J, Bergdahl M, et al. Burning mouth syndrome: prevalence and associated factors. J Oral Pathol Med. 1999; 28(8): 350–354.
    PubMed
  11. Netto FO, Diniz IM, Grossmann SM, et al. Risk factors in burning mouth syndrome: a case-control study based on patient records. Clin Oral Investig. 2011; 15(4): 571–575.
    CrossRefPubMed
  12. Suzuki N, Mashu S, Toyoda M, et al. Oral burning sensation: prevalence and gender differences in a Japanese population. Pain Pract. 2010; 10(4): 306–311.
    CrossRefPubMed
  13. Brailo V, Vuéiaeeviae-Boras V, Alajbeg IZ, et al. Oral burning symptoms and burning mouth syndrome-significance of different variables in 150 patients. Med Oral Patol Oral Cir Bucal. 2006; 11(3): E252–E255.
    PubMed
  14. Tammiala-Salonen T, Hiidenkari T, Parvinen T. Burning mouth in a Finnish adult population. Community Dent Oral Epidemiol. 1993; 21(2): 67–71.
    PubMed
  15. Kohorst JJ, Bruce AJ, Torgerson RR, et al. The prevalence of burning mouth syndrome: a population-based study. Br J Dermatol. 2015; 172: 1654–1656.
  16. Scala A, Checchi L, Montevecchi M, et al. Update on burning mouth syndrome: overview and patient management. Crit Rev Oral Biol Med. 2003; 14(4): 275–291.
    PubMed
  17. Tarkkila L, Linna M, Tiitinen A, et al. Oral symptoms at menopause--the role of hormone replacement therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001; 92(3): 276–280.
    CrossRefPubMed
  18. Ślebioda Z, Szponar E. Burning mouth syndrome - a common dental problem in perimenopausal women. Prz Menopauzalny. 2014; 13(3): 198–202.
    CrossRefPubMed
  19. Jääskeläinen SK. Pathophysiology of primary burning mouth syndrome. Clin Neurophysiol. 2012; 123(1): 71–77.
    CrossRefPubMed
  20. Mo X, Zhang J, Fan Y, et al. Thermal and mechanical quantitative sensory testing in Chinese patients with burning mouth syndrome--a probable neuropathic pain condition? J Headache Pain. 2015; 16: 84.
    CrossRefPubMed
  21. Hartmann A, Seeberger R, Bittner M, et al. Profiling intraoral neuropathic disturbances following lingual nerve injury and in burning mouth syndrome. BMC Oral Health. 2017; 17(1): 68.
    CrossRefPubMed
  22. Granot M, Nagler RM. Association between regional idiopathic neuropathy and salivary involvement as the possible mechanism for oral sensory complaints. J Pain. 2005; 6(9): 581–587.
    CrossRefPubMed
  23. Kolkka-Palomaa M, Jääskeläinen SK, Laine MA, et al. Sensory dysfunction in burning mouth syndrome. Pain. 2002; 99(1-2): 41–47.
    PubMed
  24. Ito M, Kurita K, Ito T, et al. Pain threshold and pain recovery after experimental stimulation in patients with burning mouth syndrome. Psychiatry Clin Neurosci. 2002; 56(2): 161–168.
    CrossRefPubMed
  25. Grushka M, Sessle BJ, Howley TP. Psychophysical assessment of tactile, pain and thermal sensory functions in burning mouth syndrome. Pain. 1987; 28(2): 169–184.
    PubMed
  26. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain. 2005; 115(3): 332–337.
    CrossRefPubMed
  27. Puhakka A, Forssell H, Soinila S, et al. Peripheral nervous system involvement in primary burning mouth syndrome--results of a pilot study. Oral Dis. 2016; 22(4): 338–344.
    CrossRefPubMed
  28. Beneng K, Yilmaz Z, Yiangou Y, et al. Sensory purinergic receptor P2X3 is elevated in burning mouth syndrome. Int J Oral Maxillofac Surg. 2010; 39(8): 815–819.
    CrossRefPubMed
  29. Yilmaz Z, Renton T, Yiangou Y, et al. Burning mouth syndrome as a trigeminal small fibre neuropathy: Increased heat and capsaicin receptor TRPV1 in nerve fibres correlates with pain score. J Clin Neurosci. 2007; 14(9): 864–871.
    CrossRefPubMed
  30. Jääskeläinen SK, Forssell H, Tenovuo O. Abnormalities of the blink reflex in burning mouth syndrome. Pain. 1997; 73(3): 455–460.
    PubMed
  31. Mendak M, Konopka T, Koszewicz M, et al. Badanie potencjałów wywołanych i odruchu mrugania u pacjentów z zespołem pieczenia jamy ustnej lub chorobą Parkinsona. Dent Med Probl. 2010: 169–76.
  32. Grémeau-Richard C, Dubray C, Aublet-Cuvelier B, et al. Effect of lingual nerve block on burning mouth syndrome (stomatodynia): a randomized crossover trial. Pain. 2010; 149(1): 27–32.
    CrossRefPubMed
  33. Wood PB. Role of central dopamine in pain and analgesia. Expert Rev Neurother. 2008; 8(5): 781–797.
    CrossRefPubMed
  34. Clifford TJ, Warsi MJ, Burnett CA, et al. Burning mouth in Parkinson's disease sufferers. Gerodontology. 1998; 15(2): 73–78.
    PubMed
  35. Jääskeläinen SK, Rinne JO, Forssell H, et al. Role of the dopaminergic system in chronic pain -- a fluorodopa-PET study. Pain. 2001; 90(3): 257–260.
    PubMed
  36. Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain. 2003; 101(1-2): 149–154.
    PubMed
  37. Coon EA, Laughlin RS, Coon EA, et al. Burning mouth syndrome in Parkinson's disease: dopamine as cure or cause? J Headache Pain. 2012; 13(3): 255–257.
    CrossRefPubMed
  38. Woda A, Dao T, Gremeau-Richard C. Steroid dysregulation and stomatodynia (burning mouth syndrome). J Orofac Pain. 2009; 23(3): 202–210.
    PubMed
  39. Koszewicz M, Mendak M, Konopka T, et al. The characteristics of autonomic nervous system disorders in burning mouth syndrome and Parkinson disease. J Orofac Pain. 2012; 26(4): 315–320.
    PubMed
  40. Nosratzehi T, Salimi S, Parvaee A. Comparison of Salivary Cortisol and α-amylase Levels and Psychological Profiles in Patients with Burning Mouth Syndrome. Spec Care Dentist. 2017; 37(3): 120–125.
    CrossRefPubMed
  41. Kim HI, Kim YY, Chang JY, et al. Salivary cortisol, 17β-estradiol, progesterone, dehydroepiandrosterone, and α-amylase in patients with burning mouth syndrome. Oral Dis. 2012; 18(6): 613–620.
    CrossRefPubMed
  42. Borelli V, Marchioli A, Di Taranto R, et al. Neuropeptides in saliva of subjects with burning mouth syndrome: a pilot study. Oral Dis. 2010; 16(4): 365–374.
    CrossRefPubMed
  43. Boras VV, Savage NW, Brailo V, et al. Salivary and serum levels of substance P, neurokinin A and calcitonin gene related peptide in burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2010; 15(3): e427–e431.
    PubMed
  44. Amenábar JM, Pawlowski J, Hilgert JB, et al. Anxiety and salivary cortisol levels in patients with burning mouth syndrome: case-control study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105(4): 460–465.
    CrossRefPubMed
  45. de Moura SA, de Sousa JM, Lima DF, et al. Burning mouth syndrome (BMS): sialometric and sialochemical analysis and salivary protein profile. Gerodontology. 2007; 24(3): 173–176.
    CrossRefPubMed
  46. Poon R, Su N, Ching V, et al. Reduction in unstimulated salivary flow rate in burning mouth syndrome. Br Dent J. 2014; 217(7): E14.
    CrossRefPubMed
  47. Lee YC, Hong IK, Na SY, et al. Evaluation of salivary function in patients with burning mouth syndrome. Oral Dis. 2015; 21(3): 308–313.
    CrossRefPubMed
  48. Maina G, Albert U, Gandolfo S, et al. Personality disorders in patients with burning mouth syndrome. J Pers Disord. 2005; 19(1): 84–93.
    CrossRefPubMed
  49. Galli F, Lodi G, Sardella A, et al. Role of psychological factors in burning mouth syndrome: A systematic review and meta-analysis. Cephalalgia. 2017; 37(3): 265–277.
    CrossRefPubMed
  50. Adamo D, Schiavone V, Aria M, et al. Sleep disturbance in patients with burning mouth syndrome: a case-control study. J Orofac Pain. 2013; 27(4): 304–313.
    PubMed
  51. Lopez-Jornet P, Lucero-Berdugo M, Castillo-Felipe C, et al. Assessment of self-reported sleep disturbance and psychological status in patients with burning mouth syndrome. J Eur Acad Dermatol Venereol. 2015; 29(7): 1285–1290.
    CrossRefPubMed
  52. Salort-Llorca C, Mínguez-Serra MP, Silvestre FJ. Drug-induced burning mouth syndrome: a new etiological diagnosis. Med Oral Patol Oral Cir Bucal. 2008; 13(3): E167–E170.
    PubMed
  53. Friedman DI. Topirimate-induced burning mouth syndrome. Headache. 2010; 50(8): 1383–1385.
    CrossRefPubMed
  54. Femiano F, Lanza A, Buonaiuto C, et al. Burning mouth syndrome and burning mouth in hypothyroidism: proposal for a diagnostic and therapeutic protocol. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105(1): e22–e27.
    CrossRefPubMed
  55. Klasser GD, Epstein JB, Villines D, et al. Diagnostic dilemma: the enigma of an oral burning sensation. J Can Dent Assoc. 2011; 77(6): b146.
    PubMed
  56. Ostrowski J. Palenie w obrębie jamy ustnej i gardła nie jest pozaprzełykowym objawem choroby refluksowej przełyku. Gastroenterologia Kliniczna. 2010; 2: 112–116.
  57. Becker S, Schmidt C, Berghaus A, et al. Does laryngopharyngeal reflux cause intraoral burning sensations? A preliminary study. Eur Arch Otorhinolaryngol. 2011; 268(9): 1375–1381.
    CrossRefPubMed
  58. Sardella A, Lodi G, Demarosi F, et al. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis. 2006; 12(2): 152–155.
    CrossRefPubMed
  59. Tait RC, Ferguson M, Herndon CM. Chronic orofacial pain: burning mouth syndrome and other neuropathic disorders. J Pain Manag Med. 2017; 3(1).
    PubMed
  60. Fischoff DK, Spivakovsky S. Little evidence to support or refute interventions for the management of burning mouth syndrome. Evid Based Dent. 2017; 18(2): 57–58.
    CrossRefPubMed
  61. Sun A, Wu KM, Wang YP, et al. Burning mouth syndrome: a review and update. J Oral Pathol Med. 2013; 42(9): 649–655.
    CrossRefPubMed
  62. Elokely K, Velisetty P, Delemotte L, et al. Understanding TRPV1 activation by ligands: Insights from the binding modes of capsaicin and resiniferatoxin. Proc Natl Acad Sci U S A. 2016; 113(2): E137–E145.
    CrossRefPubMed
  63. Derry S, Rice ASc, Cole P, et al. Topical capsaicin (high concentration) for chronic neuropathic pain in adults. Cochrane Database Syst Rev. 2017; 1: CD007393.
    CrossRefPubMed
  64. Jørgensen MR, Pedersen AM. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome. Acta Odontol Scand. 2017; 75(2): 130–136.
    CrossRefPubMed
  65. Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, et al. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal. 2012; 17(1): e1–e4.
    PubMed
  66. Marino R, Torretta S, Capaccio P, et al. Different therapeutic strategies for burning mouth syndrome: preliminary data. J Oral Pathol Med. 2010; 39(8): 611–616.
    CrossRefPubMed
  67. Petruzzi M, Lauritano D, De Benedittis M, et al. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med. 2004; 33(2): 111–114.
    PubMed
  68. Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E. Response to topical clonazepam in patients with burning mouth syndrome: a clinical study. Bull Group Int Rech Sci Stomatol Odontol. 2010; 49(1): 19–29.
    PubMed
  69. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain. 2004; 108(1-2): 51–57.
    CrossRefPubMed
  70. Heckmann SM, Kirchner E, Grushka M, et al. A double-blind study on clonazepam in patients with burning mouth syndrome. Laryngoscope. 2012; 122(4): 813–816.
    CrossRefPubMed
  71. Heckmann SM, Heckmann JG, Ungethüm A, et al. Gabapentin has little or no effect in the treatment of burning mouth syndrome - results of an open-label pilot study. Eur J Neurol. 2006; 13(7): e6–e7.
    CrossRefPubMed
  72. López-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal. 2011; 16(5): e635–e640.
    PubMed
  73. López V, Alonso V, Martí N, et al. Marked response of burning mouth syndrome to pregabalin treatment. Clin Exp Dermatol. 2009; 34(7): e449–e450.
    CrossRefPubMed
  74. Ito M, Tokura T, Yoshida K, et al. Five Patients With Burning Mouth Syndrome in Whom an Antidepressant (Serotonin-Noradrenaline Reuptake Inhibitor) Was Not Effective, but Pregabalin Markedly Relieved Pain. Clin Neuropharmacol. 2015; 38(4): 158–161.
    CrossRefPubMed
  75. Siniscalchi A, Gallelli L, Marigliano NM, et al. Use of topiramate for glossodynia. Pain Med. 2007; 8(6): 531–534.
    CrossRefPubMed
  76. Molina Seguin J, Domínguez Mayoral AM, Viguera Romero FJ. Burning mouth syndrome related to the intake of topiramate. Headache. 2014; 54(4): 755–756.
    CrossRefPubMed
  77. Huang W, Rothe MJ, Grant-Kels JM. The burning mouth syndrome. J Am Acad Dermatol. 1996; 34(1): 91–98.
    PubMed
  78. Sindrup SH, Otto M, Finnerup NB, et al. Antidepressants in the treatment of neuropathic pain. Basic Clin Pharmacol Toxicol. 2005; 96(6): 399–409.
    CrossRefPubMed
  79. Maina G, Vitalucci A, Gandolfo S, et al. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J Clin Psychiatry. 2002; 63(1): 38–43.
    PubMed
  80. Yamazaki Y, Hata H, Kitamori S, et al. An open-label, noncomparative, dose escalation pilot study of the effect of paroxetine in treatment of burning mouth syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009; 107(1): e6–11.
    CrossRefPubMed
  81. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofac Pain. 1999; 13(2): 83–88.
    PubMed
  82. Mignogna MD, Adamo D, Schiavone V, et al. Burning mouth syndrome responsive to duloxetine: a case report. Pain Med. 2011; 12(3): 466–469.
    CrossRefPubMed
  83. Kim YD, Lee JH, Shim JH. Duloxetine in the treatment of burning mouth syndrome refractory to conventional treatment: A case report. J Int Med Res. 2014; 42(3): 879–883.
    CrossRefPubMed
  84. Fenelon M, Quinque E, Arrive E, et al. Pain-relieving effects of clonazepam and amitriptyline in burning mouth syndrome: a retrospective study. Int J Oral Maxillofac Surg. 2017 [Epub ahead of print].
    CrossRefPubMed
  85. Rodriguez-Cerdeira C, Sanchez-Blanco E. Treatment of burning mouth syndrome with amisulpride. J Clin Med Res. 2012; 4(3): 167–171.
    CrossRefPubMed
  86. Gick CL, Mirowski GW, Kennedy JS, et al. Treatment of glossodynia with olanzapine. J Am Acad Dermatol. 2004; 51(3): 463–465.
    CrossRefPubMed
  87. Ueda N, Kodama Y, Hori H, et al. Two cases of burning mouth syndrome treated with olanzapine. Psychiatry Clin Neurosci. 2008; 62(3): 359–361.
    CrossRefPubMed
  88. Ferensztajn EŁ, Łojko D, Rybakowski J. Zespół pieczenia w jamie ustnej (burning mouth syndrome): korzystny wynik leczenia olanzapiną. Farmakoterapia w Psychiatrii i Neurologii. 2012: 159–163.
  89. Stuginski-Barbosa J, Rodrigues GGR, Bigal ME, et al. Burning mouth syndrome responsive to pramipexol. J Headache Pain. 2008; 9(1): 43–45.
    CrossRefPubMed
  90. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med. 2002; 31(5): 267–269.
    PubMed
  91. Palacios-Sánchez B, Moreno-López LA, Cerero-Lapiedra R, et al. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial. Med Oral Patol Oral Cir Bucal. 2015; 20(4): e435–e440.
    PubMed
  92. Carbone M, Pentenero M, Carrozzo M, et al. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain. 2009; 13(5): 492–496.
    CrossRefPubMed
  93. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: a randomized, placebo-treatment study. J Oral Rehabil. 2009; 36(1): 52–57.
    CrossRefPubMed
  94. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome--a randomized double-blind placebo-controlled trial. J Oral Pathol Med. 2009; 38(3): 254–261.
    CrossRefPubMed
  95. López-Jornet P, Camacho-Alonso F, Molino-Pagan D, et al. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis. 2011; 17(3): 277–282.
    CrossRefPubMed
  96. dos Santos Ld, de Andrade SC, Nogueira GEC, et al. Phototherapy on the Treatment of Burning Mouth Syndrome: A Prospective Analysis of 20 Cases. Photochem Photobiol. 2015; 91(5): 1231–1236.
    CrossRefPubMed
  97. Spanemberg JC, López López J, de Figueiredo MA, et al. Efficacy of low-level laser therapy for the treatment of burning mouth syndrome: a randomized, controlled trial. J Biomed Opt. 2015; 20(9): 098001.
    CrossRefPubMed
  98. Arduino PG, Cafaro A, Garrone M, et al. A randomized pilot study to assess the safety and the value of low-level laser therapy versus clonazepam in patients with burning mouth syndrome. Lasers Med Sci. 2016; 31(4): 811–816.
    CrossRefPubMed
  99. Miziara ID, Filho BC, Oliveira R, et al. Group psychotherapy: an additional approach to burning mouth syndrome. J Psychosom Res. 2009; 67(5): 443–448.
    CrossRefPubMed
  100. Humphris GM, Longman LP, Field EA. Cognitive-behavioural therapy for idiopathic burning mouth syndrome: a report of two cases. Br Dent J. 1996; 181(6): 204–208.
    PubMed
  101. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J Oral Pathol Med. 1995; 24(5): 213–215.
    PubMed

Informacje o plikach cookie

Niezbędne pliki cookie

Zawsze aktywne

Te pliki cookie są niezbędne do prawidłowego wyświetlania i działania strony internetowej. Zablokowanie ich może spowodować nieprawidłowe działanie strony.

Analityczne pliki cookie

W ramach naszej strony internetowej korzystamy z narzędzi analitycznych, takich jak Google Analytics, które umożliwiają nam weryfikację ruchu na stronie internetowej. Narzędzia te mogą wymagać użycia plików cookie.

Społecznościowe pliki cookie

Są to pliki cookie powiązane z portalami społecznościowymi, z których korzystamy. Zaakceptowanie ich pozwoli na powiązanie Twojej wizyty na stronie z naszymi profilami w mediach społecznościowych.

Marketingowe pliki cookie

Są to pliki cookie odpowiedzialne za prowadzenie działań reklamowych i marketingowych - zgoda na ich wykorzystanie pozwoli nam kierować do Ciebie reklamy, bazujące na podstawie Twoich wcześniejszych aktywności w ramach naszej stronie internetowej.

Copyright © 2023-2024 Via Medica Regulamin Polityka cookies Polityka prywatności Nota prawna